Gara Jalqabaatti › Dhibee Gaddii Guddaa › Florida › Orlando
Qorannoo klinikaalii Dhibee Gaddii Guddaa Orlando, FL keessatti
Qorannoo 19 Dhibee Gaddii Guddaa f Orlando fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
Namoota walitti qabaa jiraSadarkaa 3
- Nova Psychiatry INC, Orlando
A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
Namoota walitti qabaa jiraSadarkaa 2
- Clinical Neuroscience Solutions Inc. - Orlando, Orlando
- K2 Medical Research - Maitland, Maitland · Miili 6 fagaatti
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
Namoota walitti qabaa jiraSadarkaa 3
- Accel Research Sites - Maitland, Maitland · Miili 6 fagaatti
A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
Namoota walitti qabaa jiraSadarkaa 2
- Seaport Investigator Site, Orlando
ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response
Namoota walitti qabaa jiraSadarkaa 2
- Clinical Neuroscience Solutions, Inc., Orlando
A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
Namoota walitti qabaa jiraSadarkaa 2
- Draig Clinical Site, Orlando
- Draig Clinical Site, Orlando
A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
Namoota walitti qabaa jiraSadarkaa 2
- Draig Clinical Site, Orlando
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
Namoota walitti qabaa jiraSadarkaa 3
- Clinical Neuroscience Solutions, LLC (Orlando), Orlando
- Charter Research, Orlando
- K2 Medical Research (Maitland), Maitland · Miili 6 fagaatti
NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Namoota walitti qabaa jiraSadarkaa 3
- Neurocrine Clinical Site, Maitland · Miili 6 fagaatti
A Study of Brenipatide in Adult Participants With Major Depressive Disorder
Namoota walitti qabaa jiraSadarkaa 3
- Charter Research - Orlando, Orlando
- K2 Medical Research - Maitland, Maitland · Miili 6 fagaatti
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
Namoota walitti qabaa jiraSadarkaa 3
- Clinical Neuroscience Solutions, Inc., Orlando
Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
Namoota walitti qabaa jiraSadarkaa 2
- Clinical Neuroscience Solutions, Inc., Orlando
A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Namoota walitti qabaa jiraSadarkaa 3
- Neurocrine Clinical Site, Orlando
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Namoota walitti qabaa jiraSadarkaa 3
- Neurocrine Clinical Site, Maitland · Miili 6 fagaatti
- Neurocrine Clinical Site, Maitland · Miili 6 fagaatti
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
Namoota walitti qabaa jiraSadarkaa 2
- Clinical Neuroscience Solutions - Orlando - East South Street /ID# 277558, Orlando
Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Namoota walitti qabaa jiraSadarkaa 3
- Neurocrine Clinical Site, Maitland · Miili 6 fagaatti
Targeting Network Dysfunction in Apathy of Late-life Depression Using Digital Therapeutics
Namoota walitti qabaa jira
- AdventHealth Neuroscience Institute, Orlando
Study of ALTO-300 in MDD
Namoota walitti qabaa jiraSadarkaa 2
- Site 159, Clermont · Miili 24 fagaatti
A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
Namoota walitti qabaa jiraSadarkaa 4
- Clinical Research Site, Orlando
- Clinical Research Site, Orlando
- Clinical Research Site, Orlando
Qorannoo Dhibee Gaddii Guddaa magaalota biroo keessatti
- New York City, NYQorannoo 37
- Boston, MAQorannoo 31
- Atlanta, GAQorannoo 25
- Philadelphia, PAQorannoo 23
- Miami, FLQorannoo 18
- Chicago, ILQorannoo 17
- Tampa, FLQorannoo 17
- Houston, TXQorannoo 16
- San Diego, CAQorannoo 16
- Little Rock, ARQorannoo 14
- Orange, CAQorannoo 13
- Austin, TXQorannoo 13
Qorannoo biroo Orlando keessatti
- Kansara Qara'a Non-Small CellQorannoo 44
- ObesityQorannoo 31
- Kansara MetastatikiiQorannoo 29
- Baayyee UlfaataaQorannoo 27
- Dhukkubaa AlzheimerQorannoo 25
- Sukkaraa Gosa 2Qorannoo 24
- Saree (Gosoota Hunda)Qorannoo 24
- Saree OljooQorannoo 23
- Kansarii OvariiQorannoo 22
- Colitis UlcerativeQorannoo 22
- Dhibee QaraQorannoo 21
- Kansarii ColorectalQorannoo 19
Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.